299 related articles for article (PubMed ID: 22576629)
1. Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome.
Hiramatsu M; Oguri M; Kato K; Horibe H; Fujimaki T; Watanabe S; Satoh K; Aoyagi Y; Tanaka M; Shin DJ; Lee JH; Jang Y; Yamada Y
Int J Mol Med; 2012 Jul; 30(1):185-92. PubMed ID: 22576629
[TBL] [Abstract][Full Text] [Related]
2. Association of a genetic variant of BTN2A1 with metabolic syndrome in East Asian populations.
Oguri M; Kato K; Yoshida T; Fujimaki T; Horibe H; Yokoi K; Watanabe S; Satoh K; Aoyagi Y; Tanaka M; Yoshida H; Shinkai S; Nozawa Y; Shin DJ; Lee JH; Jang Y; Yamada Y
J Med Genet; 2011 Nov; 48(11):787-92. PubMed ID: 21784758
[TBL] [Abstract][Full Text] [Related]
3. Association of a polymorphism of BTN2A1 with dyslipidemia in community-dwelling individuals.
Horibe H; Ueyama C; Fujimaki T; Oguri M; Kato K; Ichihara S; Yamada Y
Mol Med Rep; 2014 Mar; 9(3):808-12. PubMed ID: 24452779
[TBL] [Abstract][Full Text] [Related]
4. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.
Komurcu-Bayrak E; Onat A; Poda M; Humphries SE; Palmen J; Guclu F; Can G; Erginel-Unaltuna N
Clin Chem Lab Med; 2008; 46(6):778-84. PubMed ID: 18601598
[TBL] [Abstract][Full Text] [Related]
5. The Relation between Metabolic Syndrome Risk Factors and Genetic Variations of Apolipoprotein V in Relation with Serum Triglyceride and HDL-C Level.
Fallah MS; Sedaghatikhayat B; Guity K; Akbari F; Azizi F; Daneshpour MS
Arch Iran Med; 2016 Jan; 19(1):46-50. PubMed ID: 26702748
[TBL] [Abstract][Full Text] [Related]
6. Association of genetic variants with dyslipidemia and chronic kidney disease in a longitudinal population-based genetic epidemiological study.
Yamada Y; Matsui K; Takeuchi I; Fujimaki T
Int J Mol Med; 2015 May; 35(5):1290-300. PubMed ID: 25813695
[TBL] [Abstract][Full Text] [Related]
7. Triglyceride-raising APOA5 genetic variants are associated with obesity and non-HDL-C in Chinese children and adolescents.
Zhu WF; Wang CL; Liang L; Shen Z; Fu JF; Liu PN; Lv LQ; Zhu YM
Lipids Health Dis; 2014 Jun; 13():93. PubMed ID: 24903888
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants of apolipoprotein A5 T-1131C and apolipoprotein E common polymorphisms and their relationship to features of metabolic syndrome in adult dyslipidemic patients.
Novotny D; Vaverkova H; Karasek D; Malina P
Clin Biochem; 2014 Aug; 47(12):1015-21. PubMed ID: 24709297
[TBL] [Abstract][Full Text] [Related]
9. The polymorphism -1131T>C in apolipoprotein A5 gene is associated with dyslipidemia in Brazilian subjects.
Ferreira CN; Carvalho MG; Fernandes AP; Santos IR; Rodrigues KF; Lana AM; Almeida CR; Loures-Vale AA; Gomes KB; Sousa MO
Gene; 2013 Mar; 516(1):171-5. PubMed ID: 23266809
[TBL] [Abstract][Full Text] [Related]
10. Association of a polymorphism of BTN2A1 with dyslipidemia in East Asian populations.
Fujimaki T; Kato K; Oguri M; Yohida T; Horibe H; Yokoi K; Watanabe S; Satoh K; Aoyagi Y; Tanaka M; Yoshida H; Shinkai S; Nozawa Y; Shin DJ; Lee JH; Jang Y; Yamada Y
Exp Ther Med; 2011 Jul; 2(4):745-749. PubMed ID: 22977569
[TBL] [Abstract][Full Text] [Related]
11. Genetic association of APOA5 and APOE with metabolic syndrome and their interaction with health-related behavior in Korean men.
Son KY; Son HY; Chae J; Hwang J; Jang S; Yun JM; Cho B; Park JH; Kim JI
Lipids Health Dis; 2015 Sep; 14():105. PubMed ID: 26365620
[TBL] [Abstract][Full Text] [Related]
12. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
[TBL] [Abstract][Full Text] [Related]
13. Association of polymorphisms of BTN2A1 and ILF3 with myocardial infarction in Japanese individuals with different lipid profiles.
Yoshida T; Kato K; Oguri M; Horibe H; Kawamiya T; Yokoi K; Fujimaki T; Watanabe S; Satoh K; Aoyagi Y; Tanaka M; Yoshida H; Shinkai S; Nozawa Y; Yamada Y
Mol Med Rep; 2011; 4(3):511-8. PubMed ID: 21468600
[TBL] [Abstract][Full Text] [Related]
14. Association of Apolipoprotein A5 Gene Polymorphisms with Metabolic Syndrome in the Korean Population.
Kim YR; Hong SH
Genet Test Mol Biomarkers; 2016 Mar; 20(3):130-6. PubMed ID: 26760709
[TBL] [Abstract][Full Text] [Related]
15. Association of APOA5 c.553G>T polymorphism with type 2 diabetes mellitus in a Chinese population.
Zhai G; Wen P; Guo L; Chen L
Clin Chem Lab Med; 2006; 44(11):1313-6. PubMed ID: 17087641
[TBL] [Abstract][Full Text] [Related]
16. APOA5-1131T>C genotype effects on apolipoprotein A5 and triglyceride levels in response to dietary intervention and regular exercise (DIRE) in hypertriglyceridemic subjects.
Jang Y; Chae JS; Kim OY; Park HJ; Kim JY; Paik JK; Lee SH; Lee JH
Atherosclerosis; 2010 Aug; 211(2):512-9. PubMed ID: 20392444
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the distribution of plasma HDL subclasses and the polymorphisms of APOA5 in hypertriglyceridemia.
Long S; Chen Z; Han Y; Christopher DM; Zhang C; Yang Y; Tian Y
Clin Biochem; 2013 Jun; 46(9):733-9. PubMed ID: 23499587
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of obesity related to total energy intake with the APOA5-1131T > C polymorphism in Korean premenopausal women.
Lim HH; Choi M; Kim JY; Lee JH; Kim OY
Nutr Res; 2014 Oct; 34(10):827-36. PubMed ID: 25263629
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein A5 T-1131C variant and risk for metabolic syndrome in obese adolescents.
Zaki M; Amr K
Gene; 2014 Jan; 534(1):44-7. PubMed ID: 24161374
[TBL] [Abstract][Full Text] [Related]
20. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
Niculescu LS; Vlădică M; Sima AV
Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
